Hillstream BioPharma Regains Nasdaq Compliance

HILSDelisted Stock  USD 0.39  0.01  2.50%   
Slightly above 62% of Hillstream Biopharma's investor base is looking to short. The analysis of current outlook of investing in Hillstream Biopharma suggests that many traders are alarmed regarding Hillstream Biopharma's prospects. Hillstream Biopharma's investing sentiment can be driven by a variety of factors including economic data, Hillstream Biopharma's earnings reports, geopolitical events, and overall market trends.
  
Hillstream BioPharma Regains Nasdaq Compliance

Read at investing.com
Investing News at Macroaxis
  

Hillstream Biopharma Fundamental Analysis

We analyze Hillstream Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hillstream Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hillstream Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Outstanding

Shares Outstanding Comparative Analysis

Hillstream Biopharma is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Hillstream Biopharma Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Hillstream Biopharma stock to make a market-neutral strategy. Peer analysis of Hillstream Biopharma could also be used in its relative valuation, which is a method of valuing Hillstream Biopharma by comparing valuation metrics with similar companies.

Peers

Hillstream Biopharma Related Equities

IMMXImmix Biopharma   19.39   
0%
100.0%
UNCYUnicycive Therapeutics   15.25   
0%
78.0%
KPRXKiora Pharmaceuticals   3.48   
0%
17.0%
VRAXVirax Biolabs   2.48   
0%
12.0%
QNRXQuoin Pharmaceuticals   1.69   
0%
8.0%
REVBRevelation Biosciences   1.33   
0%
6.0%
PALIPalisade Bio   0.83   
0%
4.0%
CDIOCardio Diagnostics   3.23   
16.0%
0%
ZVSAZyVersa Therapeutics   3.60   
18.0%
0%
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Hillstream Stock

If you are still planning to invest in Hillstream Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hillstream Biopharma's history and understand the potential risks before investing.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Stocks Directory
Find actively traded stocks across global markets
Global Correlations
Find global opportunities by holding instruments from different markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk